Wire flash
PoliticsPolymarket: Trump expected to announce new drug-pricing deals to lower prescription costs
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
According to a post on Polymarket, former President Donald Trump is expected to announce a new round of drug-pricing deals aimed at lowering prescription costs. The announcement, described as forthcoming, signals a continued focus on pharmaceutical pricing as a policy priority. The specific details of the deals, including which drugs or companies are involved, have not yet been disclosed. This development follows previous efforts by the Trump administration to address high drug prices through executive orders and negotiations. The post does not provide a timeline for the announcement or any confirmation from official sources. The news is based on a single source item from a prediction market platform, which may reflect market speculation rather than confirmed reporting.
Source report
JUST IN — President Donald Trump is expected to announce a new round of drug-pricing deals aimed at lowering prescription costs.
Source
PolymarketNeutral / independent
Part of this Story
Trump announces drug pricing deals with nine mid-sized pharma firms, projected to save $600 billion